News
MAY FARAJ: WOMAN OF SCIENCE AND HEART (May Faraj, UdeM and IRCM)
11 November 2019
General Public News
The clinical and basic research of May Faraj explores novel mechanisms leading to the development of cardiometabolic diseases in humans, such as type 2 diabetes and atherosclerosis. In particular, her team examines the role of atherogenic lipoproteins, chronic inflammation and dysfunctional white adipose tissue in this process.
Moreover, their clinical trials examine the role of various nutritional interventions, such as supplementation with omega-3 fatty acids, as therapeutic tools to reverse early cardiometabolic abnormalities. They hope that their translational studies would aid in the primary prevention of cardiometabolic diseases in humans, particularly among overweight and obese individuals.
Here are some public links for May Faraj’s research team:
- May Faraj: Femme de science et de cœur (University of Montreal – Researcher’s profile – French text):
https://nutrition.umontreal.ca/departement/professeurs/profil/faraj-may/in15272/
- Manger du bacon pour aider la recherche sur le diabète “Journal Metro” (French text):
- A five-course breakfast to track risk factors for type 2 diabetes (IRCM press release):
https://ircm.qc.ca/en/news/five-course-breakfast-track-risk-factors-type-2-diabetes
- 25 symptômes qui doivent alerter les femmes (Châtelaine – French text):
https://fr.chatelaine.com/sante/25-symptomes-qui-doivent-alerter-les-femmes/
- New mechanism to prevent type 2 diabetes in obese individuals (Health Canal):
- Nutrition, Lipoproteins and Cardiometabolic Diseases (IRCM Research unit, under the direction of May Faraj):
